Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia

NCT00391560 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AEterna Zentaris